Autoimmunity roots of the thrombotic events after COVID-19 vaccinationCOVID-19 예방접종 후 혈전증의 자가면역 뿌리Review Published on 2021-11-012022-09-12 Journal: Autoimmunity reviews [Category] MERS, SARS, 진단, [키워드] Adenoviral vector-based vaccine anti-SARS-CoV-2 vaccine Autoimmune reaction coronavirus disease COVID-19 COVID-19 vaccination Diagnosis DVT Effectiveness Factor Host immune individual induce involved Lipid Lipid nanoparticle-mRNA-based vaccine pandemic Pathogenesis pathogenic mechanism pathology prothrombotic syndrome Risk factors thrombosis thrombotic thrombotic event Treatment triggered vaccination Vaccine vaccine-induced immune thrombotic thrombocytopenia [DOI] 10.1016/j.autrev.2021.102941 PMC 바로가기 [Article Type] Review
Vaccine-induced thrombotic thrombocytopenia following coronavirus vaccine: A narrative reviewSystematic Review / Meta-analysis Published on 2021-10-302022-10-28 Journal: Annals of Medicine and Surgery [Category] COVID-19, [키워드] benefit Clinical diagnosis coronavirus COVID COVID-19 COVID-19 vaccine death Diagnosis effective global healthcare highlight incidence management mechanism Novel coronavirus Older pandemic pathophysiology post-COVID-19 vaccination preexisting comorbidities preventive measures raised reduced reported safety precautions safety profile Smokers thrombosis thrombotic thrombotic event Thrombotic thrombocytopenia vaccination Vaccine Vaccine hesitancy Vaccine induced immune thrombotic thrombocytopenia Vaccine induced thrombotic thrombocytopenia Vaccines VITT with COVID-19 [DOI] 10.1016/j.amsu.2021.102988 PMC 바로가기 [Article Type] Systematic Review / Meta-analysis
Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched StudyArticle Published on 2021-10-262022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] acute infectious respiratory disease administration adverse impact age Anticoagulant bleeding cause clinical clinical variable Complication COVID-19 COVID-19 group cumulative Cytokine storm Diabetes Mellitus diagnosed Diagnosis disease etiological excessive inflammation high risk hypoxia In-hospital incidence no significant difference occurred Other Patient patients with COVID-19 predictor Prognosis prothrombotic state respiratory Respiratory disease SARS-COV-2 infection severe COVID-19 significant difference solid cancer stroke subpopulation Thromboembolic event Thromboembolic events thrombosis thrombotic event treated two group two groups venous Venous thrombosis with COVID-19 [DOI] 10.3390/jcm10214973 PMC 바로가기 [Article Type] Article
Rapid Detection and Inhibition of SARS‐CoV‐2‐Spike Mutation‐Mediated MicrothrombosisResearch Article Published on 2021-10-232022-10-28 Journal: Advanced Science [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome adverse outcome age antibodies binding Blood Blood coagulation boost can be used coated with coronavirus coronavirus disease COVID‐19 patients D614G detection Endothelial cell enzyme examined genetic heterogeneity hACE2 Host immune response in viral increasingly Infection Inflammation inhibition Microfluidic chip Microthrombosis outcomes Patient patients platform presence of comorbidity protective mechanism Protein Rapid reduce reported Safe SARS‐CoV‐2 SARS‐CoV‐2 infection SARS‐CoV‐2 spike SARS‐CoV‐2 sequence spike tested therapy thought thrombosis thrombotic complication thrombotic event Thrombotic events vaccination Vaccine variant vector Whole blood [DOI] 10.1002/advs.202103266 PMC 바로가기 [Article Type] Research Article
Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort StudyMedicine Published on 2021-10-152022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] Anticoagulant anticoagulation cohort of patient COVID-19 COVID-19 patient death evaluate the effect exclusion French Hospitalization Hospitalized In-hospital in-hospital mortality intermediate intermediate dose intermediate-dose group Kaplan–Meier LMWH Microthrombosis Mortality observé occurred Patient patients with COVID-19 Primary outcome Prophylactic prophylactic treatment reduction in regimen Retrospective study SARS-CoV-2 significant difference Standard dose Standard-dose statistically significant difference thrombosis thrombotic thrombotic event treated Treatment treatment group Trigger venous worsening [DOI] 10.3389/fmed.2021.747527 PMC 바로가기 [Article Type] Medicine
Observational Study of Thrombotic Events in a Random Cohort of Hospitalized COVID-19 Patients at a Community-Based Hospital of New York City During the Beginning of the 2020 PandemicInternal Medicine Published on 2021-10-082022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Admission association Biomarker cerebrovascular accident cerebrovascular accidents (cva) conducted Confirmed COVID-19 infection Coronavirus disease 2019 correlated COVID-19 COVID-19 infection D-dimer Deep venous thrombosis deep venous thrombosis (dvt) defined DVT elevated Evidence First wave had no Healthcare system high mortality hospital hospitalized patient ICU incidence Infection intensive care morbidity Myocardial infarction New York City non-ICU Occurrence pathophysiological mechanism Patient patients Primary outcome procoagulant Pulmonary embolism Randomly regression analysis risk selected stroke thrombosis thrombotic thrombotic complication thrombotic event Troponin-I venous was measured with COVID-19 [DOI] 10.7759/cureus.18601 PMC 바로가기 [Article Type] Internal Medicine
Heparin beyond anti-coagulation항 응고를 넘어 헤파린Review Published on 2021-10-012022-08-31 Journal: Current research in translational medicine [Category] MERS, SARS, 신약개발, [키워드] among others Anticoagulant circulation Clinical studies Compound contribute Coronary artery Coronary artery disease coronavirus disease Coronavirus disease 2019 COVID-19 disease Efficacy eight extracorporeal circulation heparin increasingly investigated medical condition Medical re-purpose Non-anticoagulant efficacy. Pancreatitis pregnant renal renal disease respiratory respiratory inflammation Sepsis significantly thrombotic thrombotic event Thrombotic events Treatment Venous Thromboembolism [DOI] 10.1016/j.retram.2021.103300 PMC 바로가기 [Article Type] Review
Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective RoleCOVID-19에서 메트포르민의 치료 가능성: 보호 역할에 대한 추론Review Published on 2021-10-012022-09-11 Journal: Trends in microbiology [Category] SARS, 신약개발, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus attenuate blood glucose blood glucose control cardiovascular disease Clinical outcome Comorbidities Comorbidity complications coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 correlated COVID-19 COVID-19 infection COVID-19 infections COVID-19 patients diabetes Diabetic diabetic patient diabetic patients disease severity endothelial Endothelial dysfunction endothelial function Glucose glucose control Hospitalization hyperglycemia hypertension immune response immune responses Infection Inflammatory inhibit intensive care medication metformin modify Mortality obesity patients Potential Prognosis Reasoning role SARS-CoV-2 SARS-CoV-2 infections Severe acute respiratory syndrome severe acute respiratory syndrome coronavirus 2 severe metabolic thrombotic thrombotic event Thrombotic events viral entry while [DOI] 10.1016/j.tim.2021.03.004 PMC 바로가기 [Article Type] Review
Low levels of vitamin D were associated with coagulopathy among hospitalized coronavirus disease-19 (COVID-19) patients: A single-centered study in IndonesiaOriginal Paper Published on 2021-09-032022-10-29 Journal: Journal of Medical Biochemistry [Category] COVID-19, [키워드] association clinical Coagulopathy Coronavirus disease-19 COVID-19 COVID-19 patient CRP D-dimer D-dimer level defined Disseminated intravascular coagulation event ferritin group Hospitalization Hospitalized hospitalized COVID-19 patient hypovitaminosis Hypovitaminosis D ICU increased the risk Indonesia koagulopatija Laboratory Multivariate analysis negative correlation non-survivor Patient patients Result risk risk factor serum vitamin D thrombotic event Thrombotic events Vitamin D vitamin D level was used were recorded [DOI] 10.5937/jomb0-30228 PMC 바로가기 [Article Type] Original Paper
Thrombotic events and COVID-19 vaccinesState of the Art Published on 2021-09-012022-10-29 Journal: The international journal of tuberculosis and lung [Category] COVID-19, SARS, [키워드] administration AEs age approved benefit COVID-19 COVID-19 complication COVID-19 vaccine database death European evaluate event Factor greater Immune thrombocytopenia indicated mRNA vaccine pandemic Post-marketing surveillance proceed prothrombotic Randomised clinical trials recommendations reported review risk Safe SARS-CoV-2 severe adverse event suggested the vaccine thromboembolic thrombosis thrombotic event union vaccination Vaccine Vaccines Viral vector vaccines was performed women [DOI] 10.5588/ijtld.21.0298 PMC 바로가기 [Article Type] State of the Art